These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10435410)

  • 1. Enhancement of the acoustic startle response in rats by the dopamine D1 receptor agonist SKF 82958.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 1999 Jun; 144(4):373-80. PubMed ID: 10435410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do D1/D2 interactions regulate prepulse inhibition in rats?
    Wan FJ; Taaid N; Swerdlow NR
    Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors.
    Self DW; Belluzzi JD; Kossuth S; Stein L
    Psychopharmacology (Berl); 1996 Feb; 123(4):303-6. PubMed ID: 8867867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 2004 Jul; 174(2):228-36. PubMed ID: 14735289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
    Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
    Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA in the deep layers of the superior Colliculus/Mesencephalic reticular formation mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats.
    Meloni EG; Davis M
    J Neurosci; 2000 Jul; 20(14):5374-81. PubMed ID: 10884322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia.
    Sachdev PS; Saharov T
    Psychiatry Res; 1998 Dec; 81(3):323-32. PubMed ID: 9925183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
    Izquierdo-Claros RM; Boyano-Adánez MC; Larsson C; Gustavsson L; Arilla E
    Brain Res Mol Brain Res; 1997 Jul; 47(1-2):99-107. PubMed ID: 9221906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
    Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
    Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with low doses of the D1 antagonist NNC 756 and the D2 antagonist raclopride in monkeys previously exposed to dopamine antagonists.
    Lublin H; Gerlach J; Mørkeberg F
    Psychopharmacology (Berl); 1994 Apr; 114(3):495-504. PubMed ID: 7855208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of the acoustic startle reflex by dopamine D1 and 5-HT1A agonists and corresponding changes in c-Fos expression in the dorsal raphe of rats.
    Meloni EG; Davis M
    Psychopharmacology (Berl); 2000 Sep; 151(4):359-67. PubMed ID: 11026743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.
    Ralph-Williams RJ; Lehmann-Masten V; Geyer MA
    Neuropsychopharmacology; 2003 Jan; 28(1):108-18. PubMed ID: 12496946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
    Zackheim JA; Abercrombie ED
    Brain Res Bull; 2001 Apr; 54(6):603-7. PubMed ID: 11403986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dopamine in prepulse inhibition of acoustic startle.
    Zhang J; Forkstam C; Engel JA; Svensson L
    Psychopharmacology (Berl); 2000 Apr; 149(2):181-8. PubMed ID: 10805614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats.
    Barrett AC; Miller JR; Dohrmann JM; Caine SB
    Neuropharmacology; 2004; 47 Suppl 1():256-73. PubMed ID: 15464142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
    Lublin H; Gerlach J; Peacock L
    Psychopharmacology (Berl); 1993; 112(2-3):389-97. PubMed ID: 7871047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons.
    Nantwi KD; Schoener EP
    Gen Pharmacol; 1994 Nov; 25(7):1439-43. PubMed ID: 7896058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.